This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Jul 15;107(4):615-616.

doi: 10.1016/j.ijrobp.2019.09.026.

High Dose Cisplatin: Still the One?

Zain A Husain¹, Barbara A Burtness²

Affiliations

Affiliations

¹ Department of Radiation Oncology, University of Toronto, Sunnybrook Health Sciences Centre, Toronto ON, Canada.
² Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.

PMID: 32589986
DOI: 10.1016/j.ijrobp.2019.09.026

Comment

High Dose Cisplatin: Still the One?

Zain A Husain et al. Int J Radiat Oncol Biol Phys. 2020.

. 2020 Jul 15;107(4):615-616.

doi: 10.1016/j.ijrobp.2019.09.026.

Authors

Zain A Husain¹, Barbara A Burtness²

Affiliations

¹ Department of Radiation Oncology, University of Toronto, Sunnybrook Health Sciences Centre, Toronto ON, Canada.
² Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.

PMID: 32589986
DOI: 10.1016/j.ijrobp.2019.09.026

No abstract available

PubMed Disclaimer

Comment on

To Intensify or Not to Intensify? Consideration of Competing Risks in the Management of Locoregionally Advanced p16+ Oropharyngeal Cancer.
Simon AB, Mell LK. Simon AB, et al. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):613-614. doi: 10.1016/j.ijrobp.2018.09.034. Int J Radiat Oncol Biol Phys. 2020. PMID: 32589985 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science